Shapiro Benjamin's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc | Benjamin Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 85,070 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Benjamin Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 4,650 | 89,720 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Benjamin Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 50,000 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Shapiro Benjamin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 5,070 | 55,070 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Benjamin Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 20,000 | 20,000 (0%) | 0% | - | Common Stock |